• Sadhvi Paliwal
• Kalpana Sharma

Pseudomonas aeruginosa is a common Gram-negative bacillus associated with hospital infections and is often difficult to eradicate due to its resistant drug profile. Therefore, detection of MBL-producing Gram-negative bacilli especially Pseudomonas aeruginosa is crucial for the optimal treatment of patients particularly in critically ill and hospitalized patients, and to control the spread of resistance. There is not much information available on MBL producing Pseudomonas aeruginosa isolates from India. We therefore undertook this study to detect the MBL in Pseudomonas aeruginosa isolates obtained from hospitalized critically ill patients. Two different screening methods were used to find out their effectiveness in the detection of these isolates. Metallobeta-lactamase (MBL)-mediated resistance to carbapenems is an emerging threat in hospital isolates of Pseudomonas aeruginosa.

Hospital infection, Infected samples, MBL producing, Multi drug resistant, Resistant drug.

"METALLO BETA LACTAMASES (MBL) PRODUCTION IN CLINICAL SAMPLE (URINE AND BLOOD) OF PSEUDOMONAS AERUOGINOSA SPECIES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 6, page no.f548-f558, June-2021, Available :http://www.jetir.org/papers/JETIR2106777.pdf

"METALLO BETA LACTAMASES (MBL) PRODUCTION IN CLINICAL SAMPLE (URINE AND BLOOD) OF PSEUDOMONAS AERUOGINOSA SPECIES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 6, page no. ppf548-f558, June-2021, Available at : http://www.jetir.org/papers/JETIR2106777.pdf